Tang C - Search Results

1

EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.

Zhang Y, Su H, Rahimi M, Tochihara R, Tang C. Zhang Y, et al. Among authors: tang c. Int J Cancer. 2009 Nov 1;125(9):2021-8. doi: 10.1002/ijc.24540. Int J Cancer. 2009. PMID: 19588487 Free PMC article.

2

EGFR variant-mediated invasion by enhanced CXCR4 expression through transcriptional and post-translational mechanisms.

Rahimi M, George J, Tang C. Rahimi M, et al. Among authors: tang c. Int J Cancer. 2010 Apr 15;126(8):1850-1860. doi: 10.1002/ijc.24964. Int J Cancer. 2010. PMID: 19830694 Free PMC article.

3

TOB suppresses breast cancer tumorigenesis.

O'Malley S, Su H, Zhang T, Ng C, Ge H, Tang CK. O'Malley S, et al. Among authors: tang ck. Int J Cancer. 2009 Oct 15;125(8):1805-13. doi: 10.1002/ijc.24490. Int J Cancer. 2009. PMID: 19569230

4

3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants.

Rahimi M, Huang KL, Tang CK. Rahimi M, et al. Cancer Lett. 2010 Sep 1;295(1):59-68. doi: 10.1016/j.canlet.2010.02.014. Epub 2010 Mar 17. Cancer Lett. 2010. PMID: 20299148 Free PMC article.

5

CXCR4 suppression attenuates EGFRvIII-mediated invasion and induces p38 MAPK-dependent protein trafficking and degradation of EGFRvIII in breast cancer cells.

Rahimi M, Toth TA, Tang CK. Rahimi M, et al. Cancer Lett. 2011 Jul 1;306(1):43-51. doi: 10.1016/j.canlet.2011.02.024. Epub 2011 Mar 30. Cancer Lett. 2011. PMID: 21454012 Free PMC article.

6

Chemokine receptor CXCR4-mediated transformation of mammary epithelial cells by enhancing multiple RTKs expression and deregulation of the p53/MDM2 axis.

Su H, Sobrino Najul EJ, Toth TA, Ng CM, Lelievre SA, Fred M, Tang CK. Su H, et al. Cancer Lett. 2011 Aug 28;307(2):132-40. doi: 10.1016/j.canlet.2011.03.025. Epub 2011 May 6. Cancer Lett. 2011. PMID: 21530075

7

Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis.

Ge H, Gong X, Tang CK. Ge H, et al. Int J Cancer. 2002 Mar 20;98(3):357-61. doi: 10.1002/ijc.10224. Int J Cancer. 2002. PMID: 11920586

8

Suppression of EGFRvIII-mediated proliferation and tumorigenesis of breast cancer cells by ribozyme.

Luo X, Gong X, Tang CK. Luo X, et al. Int J Cancer. 2003 May 10;104(6):716-21. doi: 10.1002/ijc.11007. Int J Cancer. 2003. PMID: 12640678

9

Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII.

Han W, Zhang T, Yu H, Foulke JG, Tang CK. Han W, et al. Cancer Biol Ther. 2006 Oct;5(10):1361-8. doi: 10.4161/cbt.5.10.3226. Epub 2006 Oct 26. Cancer Biol Ther. 2006. PMID: 16969069 Free article.

10

Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathways.

Yu H, Gong X, Luo X, Han W, Hong G, Singh B, Tang CK. Yu H, et al. Cancer Biol Ther. 2008 Nov;7(11):1818-28. doi: 10.4161/cbt.7.11.6847. Epub 2008 Nov 24. Cancer Biol Ther. 2008. PMID: 18787418 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,705 results

Search Page

Filters